Jakarta – BRIN Public Relations. The National Research and Innovation Agency of the Republic of Indonesia (BRIN RI) through the Technical Science Research Organization (IPT RO) has the mandate to implement research and development (R&D) programs, as incorporated in the 4 Rumah Programs (Program Home, RP), one of which is health device and detection RP.

Head of BRIN IPT RO, Agus Haryono said that in this health device and detection RP, many industries have purchased licenses for BRIN research products. From these licenses, BRIN researchers can even earn royalty of up to hundreds of millions of rupiah.

“Many industries have purchased licenses for our products, and the royalty revenue from this license paid to the state in 2021 reached 2.75 billion. Researchers, under the Regulation of the Ministry of Finance, are entitled to receive royalties from licenses earned by the state from the results of research. In fact, our team has received returns of up to 400 million in 1 year,” said Agus, to Sapa Media, online, Monday (17/01).

RP, Agus explained, is a model for the implementation of R&D activities carried out at BRIN, by which RP can be carried out by all BRIN researchers by submitting proposals to jointly carry out research activities.

He said, in early 2020, when the Covid-19 pandemic broke out, research policies were focused on handling Covid-19. Then in 2021 it continued to become a large activity for health devices and detection, and continues to this day.

As a result, Agus continued, many industries have purchased licenses for BRIN products, which have an impact on state revenues, with the royalty of up to hundreds of millions for researchers.

According to him, this proves that being a researcher you do not need to be afraid of being poor if you can produce research that is beneficial to society.

“This is proof that researchers do not need to be afraid of being poor because they can carry out research activities that produce a product that is used by the community which license is bought by the industry. Every product sold has a royalty that goes into the state treasury through PNBP,” he added.

Recently, BRIN research team succeeded in developing RT-LAMP, an alternative method for testing the Covid-19 virus without a PCR tool, including the Omicron variant.

He said BRIN has, from the beginning, collaborated with the industry in developing this product. He hopes that the development of RT-LAMP products can continue with more sophisticated detection and is more convenient for the public to use.

“If RT-LAMP still collects samples through nasal swabs, people may not be comfortable. Later we will make other product variants that are more comfortable, yet the quality equals to RT-PCR. This is a challenge to the needs of the community who are really looking forward to products like this,” he concluded (tnt).